Combined chemotherapy with niclosamide and gemcitabine induced β-catenin ubiquitination, consequently downregulated the β-catenin-c-MYC signaling pathway to inhibit pancreatic cancer progression 39. This evidence concerns the gene MYC and pancreatic neoplasm.